Progesterone receptor synthesis in human meningiomas: Relation to the estrogen-induced proteins pS2 and cathepsin-D and influence of epidermal growth factor, Forskolin and phorbol ester in vitro

International Journal of Biological Markers

Volumn 13, Issue 1, 1998, Pages 16-23

  Koehorst, S G A ^a   Spapens, M E D ^a   Van Der Kallen, C J H ^a   Van 'T Verlaat, J W ^a   Blaauw, G ^b   Thijssen, J H H ^a   Blankenstein, M A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b De Wever Hospital ^*  (Netherlands)

Author keywords

cAMP; Cathepsin D; Epidermal growth factor; Meningioma; Phorbol ester; Progesterone receptor; pS2

Indexed keywords

CATHEPSIN D; EPIDERMAL GROWTH FACTOR; ESTROGEN; ESTROGEN RECEPTOR; FORSKOLIN; PHORBOL ESTER; PROGESTERONE RECEPTOR; PROTEIN PS2;

ARTICLE; BREAST TUMOR; CYTOSOL; HUMAN; HUMAN TISSUE; MENINGIOMA; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 0031822282     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460089801300104     Document Type: Article

References (32)

1. Blaauw G, Blankenstein MA, Lamberts SWJ. Sex steroid receptors in human meningiomas. Acta Neurochir 1986; 79: 42-6.
2. Blankenstein MA, Blaauw G, Lamberts SWJ, Mulder E. Presence of progesterone receptors and absence of estrogen receptors in human intracranial meningioma cytosols. Eur J Cancer Clin Oncol 1983; 19: 365-70.
3. Blankenstein MA, van der Meulen-Dijk C, Thijssen JHH. Assay of estrogen and progestin receptors in human meningioma cytosols using immunological methods. Clin Chim Acta 1987; 165: 189-95.
4. Blankenstein MA, Berns PM, Blaauw G, Mulder E, Thijssen JHH. Search for the estrogen receptor in human meningioma tissue sections with a monoclonal antibody against the human estrogen receptor. Cancer Res 1986; 46: 4268s-70s.
5. Carrol RS, Glowacka D, Dashner K, Black PM. Progesterone receptor expression in meningiomas. Cancer Res 1993; 53: 1312-6.
6. Maxwell M, Galanopolos T, Neville-Golden J, Antoniades HN. Expression of androgen and progesterone receptors in primary human meningiomas. J Neurosurg 1993; 78: 456-62.
7. Koehorst SGA, Jacobs HM, Tilanus MGJ, Bouwens AGM, Thijssen JHH, Blankenstein MA. Aberrant estrogen receptor species in human meningioma tissue. J Steroid Biochem Molec Biol 1992; 43: 57-61.
8. Koehorst SGA, Jacobs HM, Thijssen JHH, Blankenstein MA. Wild type and alternatively spliced estrogen receptor messenger RNA in human meningioma tissue and MCF7 breast cancer cells. J Steroid Biochem Molec Biol 1993; 45: 227-33.
9. Fuqua SAW, Fitzgerald SD, Allred DC et al. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res 1992; 52: 483-6.
10. Koehorst SGA, Cox JJ, Donker GH, Lopes da Silva S, Burbach JPH, Thijssen JHH, Blankenstein MA. Functional analysis of an alternatively spliced estrogen receptor lacking exon 4 isolated from MCF7 breast cancer cells and meningioma tissue. Mol Cell Endocrinol 1994; 101: 237-45.
11. Koehorst SGA, Jacobs HM, Thijssen JHH, Blankenstein MA. Detection of an estrogen receptor-like protein in human meningiomas by band shift assay using a synthetic estrogen responsive element. Br J Cancer 1993; 68: 290-4.
12. Scott GK, Kastner P, Vigne J, Benz CC. Truncated forms of DNA-binding oestrogen receptors in human breast cancer. J Clin Invest 1991; 88: 700-6.
13. Brown AMC, Jeltsch JM, Roberts M, Chambon P. Activation of the pS2 gene is a primary response to estrogen in the human breast cancer cell line MCF7. Proc Natl Acad Sci USA 1984; 81: 6344-8.
14. Cavailles V, Augereau P, Garcia M et al. Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells. Nucl Acid Res 1988; 16:1903-19.
15. Koper JW, Foekens JA, Lamberts SWJ. Effect of progesterone on the response to epidermal growth factor and other growth factors in cultured human meningioma cells. Cancer Res 1990; 50: 2604-7.
16. Aronica SM, Katzenellenbogen BS. Progesterone receptor regulation in uterine cells: Stimulation by estrogen, cyclic adenosine 3′, 5′-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors. Endocrinology 1991; 128: 2045-53.
17. Sumida C, Pasqualini JR. Stimulation of progesterone receptor by phorbol ester and cyclic AMP in fetal uterine cells. Mol Cell Endocrinol 1990; 69: 207-15.
18. Cavailles V, Garcia M, Rochefort H. Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. Mol Endocrinol 1989; 3: 552-8.
19. Bradford MM. A rapid and sensitive method for the quantitation of protein using the principle of protein dye-binding. Anal Biochem 1976; 72: 248-55.
20. Nunez AM, Jakowlev S, Briand JP et al. Characterization of the estrogen-induced pS2 protein secreted by the human breast cancer cell line MCF7. Endocrinology 1987; 121: 1759-65.
21. Rio MC, Bellocq JP, Daniel JY et al. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 1988; 241: 705-8.
22. Rio MC, Bellocq JP, Gairard B et al. Specific expression of the pS2 gene in subclasses of breast cancer - comparison with expression of the progesterone receptors and the oncogene ERRB2. Proc Natl Acad Sci USA 1987; 84: 9243-7.
23. Augerau P, Garcia M, Mattei MG et al. Cloning and sequencing of the 52K cathepsin D complementary deoxyribonucleic acid of MCF7 breast cancer cells and mapping of chromosome 11. Mol Endocrinol 1988; 2: 186-92.
24. Capony F, Morisset M, Barrett AJ et al. Phosphorylation, glycosylation and proteolytic activity of the 52K estrogen-induced protein secreted by MCF7 cells. J Cell Biol 1987; 104: 253-62.
25. Westley B, Rochefort H. A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell 1980; 20: 352-2.
26. Vignon F, Capony F, Chambon M et al. Autocrine growth stimulation of the MCF7 breast cancer cells by the estrogen-regulated 52 K protein. Endocrinology 1986: 118; 1537-45.
27. Briozzo P, Morisset M, Capony F et al. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res 1988; 48: 3688-92.
28. Rochefort H, Capony F, Garcia M, et al. Estrogen-induced lysosomal proteases secreted by breast cancer cells. A role in carcinogenesis? J Cell Biochem 1987; 35: 17-29.
29. Foekens JA, Rio MC, Seguin P et al. Prediction of relapse and survival in breast cancer patients by pS2 status. Cancer Res 1990; 50: 3832-7.
30. Bouillot P, Pellissier J-F, Devictor B, et al. Quantitative imaging of estrogen-regulated protein, and growth fraction: immunocytochemical assays in 52 meningiomas. J Neurosurg 1994; 81: 765-73.
31. Sivaparvathi M, McCutcheon I, Sawaya R, Nicholson GL, Rao JS. Expression of cysteine protease inhibitors in human gliomas en meningiomas. Clin Exp Metastasis 1996; 14: 344-50.
32. Blankenstein MA, van der Meulen-Dijk C, Thijssen JHH. Effect of steroids and antisteroids on human meningioma cells in primary culture. J Steroid Biochem 1989; 34: 419-21.